Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Clay Bernardin Thorp
Age : 51
Public asset : 161,855 USD
Linked companies : Clearside Biomedical, Inc. - PhaseBio Pharmaceuticals, Inc.
Summary 
Clay Bernardin Thorp founded 5 companies, notably: PhaseBio Pharmaceuticals, Inc., Hatteras Venture Partners and Synthematix, Inc. Currently, he holds the position of Executive Chairman at PhaseBio Pharmaceuticals, Inc. (which he founded in 2002), Director at GeneCentric Therapeutics, Inc. and General Partner of Hatteras Venture Partners (which he founded in 2000). Mr. Thorp is also on the board of 5 other companies.

In his past career Clay Bernardin Thorp held the position of Advisor at Research Triangle Ventures LLC, Chairman & Chief Executive Officer of Synthematix, Inc. (he founded the company), President for Xanthon, Inc. (he founded the company) and Director-Corporate Development at Karo Bio USA, Inc. (he founded the company).

Mr. Thorp received a graduate degree from Harvard University and an undergraduate degree from The University of North Carolina at Charlotte.


Current positions of Clay Bernardin Thorp 
NameTitle Since
Clearside Biomedical, Inc.
(Biotechnology & Medical Research)
Independent Director 2012
PhaseBio Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Executive Chairman 2014
GeneCentric Therapeutics, Inc. Director -
Rodin Therapeutics, Inc. Director -
Curoverse, Inc. Director -
Orig3n, Inc. Director -
Vigil Neuroscience, Inc. Director -
Hatteras Venture Partners General Partner 2000


Holdings of Clay Bernardin Thorp 
NameEquities%Valuation
PhaseBio Pharmaceuticals, Inc. (PHAS)
(Biotechnology & Medical Research)
32,9430.069%106,735 USD
Clearside Biomedical, Inc. (CLSD)
(Biotechnology & Medical Research)
8,0000.013%55,120 USD


Clay Bernardin Thorp: Personal Network 
Most Read News 
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Clay Bernardin Thorp : Connections